Figure 2 | Scientific Reports

Figure 2

From: PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma

Figure 2

Effect on PTEN expression upon knockdown of PTENP1-AS. (a,b) qRTPCR measuring the expression levels of PTENP1-AS and PTEN in (a) A375PR1 or (b) A375 cells upon knockdown of PTENP1-AS using gapmer ASO. (c,d) qRTPCR measuring the expression levels of PTENP1-AS and PTEN in (c) A375PR1 or (d) A375 cells upon knockdown of PTENP1-AS using siRNA. (a–d) n = 3, p-values represent two-tailed student’s t-tests.

Back to article page